Ramanan Laxminarayan
Drug Resistance Economist, Researcher and Founder of Center for Disease Dynamics, Economics & Policy
FEE RANGE: $10,000–$20,000 [FEE NOTE]
TRAVELS FROM: District of Columbia
Ramanan Laxminarayan directs the Center for Disease Dynamics, Economics & Policy. He is also a Senior Research Scholar and Lecturer at Princeton University. His keynotes expand on healthcare and issues surrounding the use of pharmaceuticals to treat illnesses. Laxminarayan has done extensive research into the antibiotic resistance movement. His keynotes often urge health professionals, as well as patients, to pay attention to the growing critical issue. Laxminarayan is known as the founder and director of the Center for Disease Dynamics, Economics & Policy. In his free time Laxminarayan lectures at Princeton University and collects extensive research on the future of health and medical care. Laxminarayan has worked on topics such as vaccination, illness economics and disease. Many of the Ramanan Laxminarayan keynotes educates audiences how they can understand and prevent antibiotic resistance for future generations.
Ramanan Laxminarayan directs the Center for Disease Dynamics, Economics & Policy. He is also a Senior Research Scholar and Lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding of drug resistance as a problem of managing a shared global resource. His keynotes expand on healthcare and issues surrounding the use of pharmaceuticals to treat illnesses
Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. In 2003-04, he served on the National Academy of Science/Institute of Medicine Committee on the Economics ofAntimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC,NPR, Reuters, Science, Wall Street Journal, and National Journal.
Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. In 2003-04, he served on the National Academy of Science/Institute of Medicine Committee on the Economics ofAntimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC,NPR, Reuters, Science, Wall Street Journal, and National Journal.
Topics:
- The Coming Crisis in Antibiotics
Antibiotic drugs save lives. But we simply use them too much — and often for non-lifesaving purposes, like treating the flu and even raising cheaper chickens. The result, says researcher Ramanan Laxminarayan, is that the drugs will stop working for everyone, as the bacteria they target grow more and more resistant. He calls on all of us (patients and doctors alike) to think of antibiotics — and their ongoing effectiveness — as a finite resource, and to think twice before we tap into it. It's a sobering look at how global medical trends can strike home.
We can help ideate, source and book speakers that aren't on our website, too. Leave an inquiry or call us at